An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy
Stopped early · Phase 3
Conditions studied: Duchenne Muscular Dystrophy
In brief
The main objective of this study is to evaluate the safety and tolerability of long-term treatment with casimersen or golodirsen in patients with Duchenne muscular dystrophy (DMD).
Key facts
- Study ID
- NCT03532542
- Run by
- Sarepta Therapeutics, Inc.
- People needed
- 171
- Starts
- 2018-08-02
- Expected to finish
- 2023-07-26
- Last updated by the study team
- 2024-09-19
Who can join
Age: 7 and older, up to 23. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Completed a clinical trial evaluating casimersen or golodirsen, per protocol.
- Is between 7 and 23 years of age, inclusive, at enrollment.
- Other inclusion/exclusion criteria apply.
Where it is running
- Neuromuscular Research Center — Phoenix, Arizona, United States
- Children's Hospital Los Angeles — Los Angeles, California, United States
- University of California Los Angeles — Los Angeles, California, United States
- Stanford Neuroscience Health Center — Palo Alto, California, United States
- Rady Children's Hospital- San Diego — San Diego, California, United States
- UF Health: University of Florida Clinical Research Center — Gainesville, Florida, United States
- NW Florida Clinical Research Group, LLC — Gulf Breeze, Florida, United States
- Rare Disease Research, LLC — Atlanta, Georgia, United States
- Ann and Robert H Lurie Childrens Hospital of Chicago — Chicago, Illinois, United States
- University of Iowa Childrens Hospital — Iowa City, Iowa, United States
- University of Kansas Medical Center — Kansas City, Kansas, United States
- Kennedy Krieger Institute — Baltimore, Maryland, United States
- Boston Children's Hospital — Boston, Massachusetts, United States
- St. Louis Children's Hospital — St Louis, Missouri, United States
- Las Vegas Clinic — Las Vegas, Nevada, United States
- University of Rochester Medical Center - Department of Neurology — Rochester, New York, United States
- Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States
- Abigail Wexner Research Institute at Nationwide Children's Hospital — Columbus, Ohio, United States
- Shriners Hospital for Children — Portland, Oregon, United States
- Children's Hospital of Pittsburgh of UPMC — Pittsburgh, Pennsylvania, United States
- Children's Medical Center Dallas — Dallas, Texas, United States
- Texas Children's Hospital — Houston, Texas, United States
- University of Utah - PPDS — Salt Lake City, Utah, United States
- Children's Hospital of The King's Daughters — Norfolk, Virginia, United States
- Children's Hospital of Wisconsin, Corporate Center Suite 540 — Milwaukee, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.